Cite Filings / SLN / 0001193125-22-042050
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Silence Therapeutics plc · Filed 2022-02-14 · Acc 0001193125-22-042050

Documents 1

  • SC 13G Amended Statement of Ownership , d306033dsc13g.htm

Around this filing

  • 2022-08-19 SC 13G Amended Statement of Ownership
  • 2022-02-14 SC 13G Amended Statement of Ownership
  • 2022-02-14 SC 13G Amended Statement of Ownership
  • 2022-02-10 SC 13G/A Amended Statement of Ownership
  • 2022-02-09 6-K Report of Foreign Issuer
  • 2022-02-07 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-12 SCHEDULE 13G/A · Raymond Debbane 4.6%
  2. 2026-11-05 SCHEDULE 13G · FMR LLC 7.1%
  3. 2026-10-13 SCHEDULE 13G/A · Tetragon Financial Group Limited 5.3%
  4. 2026-10-13 SCHEDULE 13G · Tetragon Financial Group Limited 5.2%
  5. 2026-08-13 SCHEDULE 13G/A · Raymond Debbane 7.0%
  6. 2026-08-13 SCHEDULE 13D/A · Richard Griffiths 7.97%
Loading d306033dsc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…